AZ boosts training with simulations

Share this article:
AstraZeneca has been using sales simulations to help bolster rep training for real product details behind its new asthma drug Symbicort.

“We are big believers in the use of simulations in sales training,” AstraZeneca's Mark Mallon told MM&M during a recent interview. “In addition to traditional product and disease training, we use role plays to create customers that have profiles. The representatives then call on them multiple times in the training.”

Mallon said the Symbicort training program proved to be highly effective. “Literally 10 minutes within arriving at the launch meeting, reps were detailing real physicians. We think that's very powerful.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.